INTRODUCTION
============

The process of weaning involving complex psychological, social, environmental and dietary stressors is one of the most stressful events in pig's life and can contribute to serial pathogenic and nonpathogenic immunological challenge ([@b1-ajas-27-7-1035-17]; [@b43-ajas-27-7-1035-17]). Because of the physiological and metabolic changes including transient fever, depressed feed intake and diversion of nutrients in support of immune-related processes, immune challenge is considered an important economic loss case owing to growth inhibition and reduced efficiency of gain ([@b17-ajas-27-7-1035-17]; [@b40-ajas-27-7-1035-17]). Many findings have converged to suggest that the foregoing physiological and metabolic changes induced by immunological challenge are mostly ascribed to the release of pro-inflammatory cytokines, including interleukin-1beta (IL-1β), interleukin-6 (IL-6), and tumor necrosis factor (TNF)-α ([@b19-ajas-27-7-1035-17]; [@b18-ajas-27-7-1035-17]). Therefore, modulating the secretion of these cytokines by nutritional means of using natural substances with immunomodulatory traits offers methods of reducing the negative performance of immunologically challenged animals ([@b2-ajas-27-7-1035-17]; [@b48-ajas-27-7-1035-17]).

In China, Chinese herbal ingredients are natural substances which have been widely used to improve animal health ([@b49-ajas-27-7-1035-17]; [@b22-ajas-27-7-1035-17]; [@b21-ajas-27-7-1035-17]; [@b24-ajas-27-7-1035-17]; [@b9-ajas-27-7-1035-17]). Notably, recent studies demonstrating that extracts derived from *Acanthopanax senticosus* (AS), a well-known herb widely distributing in northern regions of Korea, Japan, and China ([@b4-ajas-27-7-1035-17]; [@b36-ajas-27-7-1035-17]), improved immune responses ([@b20-ajas-27-7-1035-17]), enhanced utilization efficiency of nutrition ([@b23-ajas-27-7-1035-17]), and modulated gut health of weaned piglets ([@b48-ajas-27-7-1035-17]; [@b8-ajas-27-7-1035-17]) have gained extensive attention. Above all, *Acanthopanax senticosus* polysaccharide (ASPS) as a extract typically concentrated in the root of AS, in human and rodents, has been shown to have potent immunomodulatory activity *in vitro* and *in vivo* by improving lymphocyte proliferation ([@b3-ajas-27-7-1035-17]), inducing cytokine actions of interleukin-1beta (IL-1β) and interleukin-6 (IL-6) ([@b41-ajas-27-7-1035-17]), enhancing activities of B cells and phagocytosis of macrophages ([@b12-ajas-27-7-1035-17]), inhibiting the transferred tumor growths and ameliorating toxicities of toxic substances by immunomodulatory role of ASPS ([@b38-ajas-27-7-1035-17]). Our previous research concerning the role of ASPS on improving performance and immune function in weaned piglets have been observed ([@b10-ajas-27-7-1035-17], [@b11-ajas-27-7-1035-17]). However, within our knowledge, there is little information about the effects which ASPS exert its activities in weanling pigs under challenged condition. Therefore, the objective of current study was to determine the effects of ASPS supplementation on growth, immunity, blood parameters as well as the expression of pro-inflammatory cytokines genes in challenged piglets in order to probe into the effect on alleviation of depressed performance, especially on modulating immunological response and its underlying mechanism. We hypothesized that ASPS supplementation might bring some positive alternations in detrimental effect induced by an immunological challenge to piglets.

MATERIALS AND METHODS
=====================

All experiments were performed in accordance with the guidelines of Pig Production Association of Liaoning Province (China) and were approved by Animal Care Committee of Shenyang Agricultural University (China).

*Acanthopanax senticosus* polysaccharide preparation and analysis
-----------------------------------------------------------------

Ethanol precipitation method according to [@b50-ajas-27-7-1035-17] was used to prepare ASPS with some modification. Briefly, crushed root was boiled to obtain filtrate, which was concentrated and protein removed by Sevag method ([@b42-ajas-27-7-1035-17]). Subsequently, the solution was precipitated with ethanol to collect precipitate by centrifugation. The precipitate was dissolved in water and dialyzed for 24 h to remove the small molecular impurities, and then, the solution was concentrated again and purified by active carbon column chromatography with water and different concentration ethanol as eluent medium. Eluent was managed with reduced pressure, thus the tan powdery polysaccharide was obtained. Polysaccharide content was 92.74% measured by the phenol sulfuric acid method ([@b5-ajas-27-7-1035-17]). Polysaccharide mainly consisted of glucose residues as determined by gas chromatography assay.

Animals, management, designing
------------------------------

Experiment (from June 5, 2012, to June 25, 2012) was conducted on the scientific pig farm of Shenyang Agriculture University (China). The formal feeding period lasted for 3 wks. The experiment was a 2×2 factorial arrangement including the main factors such as dietary ASPS supplementation (0 or 800 mg/kg) ([@b10-ajas-27-7-1035-17]) and immunological challenge (lipopolysaccharide \[LPS\] or saline injection). A total of 64 crossbred piglets (Duroc×Landrace×Large White), weaned at 28 d of age with average initial body weight (BW) of 7.25±0.21 kg were randomly assigned to 2 dietary groups with 8 replicate pens of 4 pigs per pen. On d 14, pigs in random four pens of per dietary treatment were intraperitoneally injected with 100 μg/kg BW LPS (Escherichia coli serotype 055:B5, Sigma) and the others were treated with equivalent amount of saline.

All pigs were housed in an environmentally controlled confinement house with concrete-slotted floor in 16 stainless steel pens (2.0×2.1 m). Each pen was equipped with a self-feeder and a nipple drinker to allow the pigs *ad-libitum* access to feed and water. The temperature in the inner house ranged from 21.6°C±2.3°C (6:00 to 7:00 am) to 23.2°C±1.5°C (15:00 to 16:00 pm) with 25.9°C±2.1°C on average. The basal diet containing no antibiotic, presented in [Table 1](#t1-ajas-27-7-1035-17){ref-type="table"}, was formulated according to the nutrient requirements of [@b35-ajas-27-7-1035-17].

Growth performance
------------------

Surplus feed remaining in the feeder of each pen was cleared away and weighted daily to calculate average daily feed intake (ADFI). All piglets were weighed individually at the beginning of experiment to obtain the initial BW, subsequently, BW was recorded again on d 14 and 21 to determine average daily gain (ADG), and gain:feed.

Preparation of blood and spleen samples
---------------------------------------

Two samples of peripheral blood were taken from one pig randomly selected from each pen at 3 h after injection on d 14. One 5 mL sample was collected in an EDTA K~2~ anticoagulant vacuum tube that was centrifuged for 5 min at 1,960×g in a cold chamber (4°C) to prepare plasma and stored at −20°C for analysis of hormones, biochemical parameters and cytokines. Another sample was collected in vacuum tubes without anticoagulant to determine blood cell counts and lymphocyte proliferation.

On d 21, the piglets whose blood was sampled on d 14 were slaughtered to take out spleens, which were wrapped in sterilized gauze and frozen in liquid nitrogen immediately, then stored at −80°C for subsequent RNA analysis.

Blood cell counts analysis
--------------------------

The peripheral leucocyte number and lymphocyte counts were determined using automatic blood analyzer (Uritest-3000, China).

Lymphocyte proliferation assay
------------------------------

According to the method of [@b34-ajas-27-7-1035-17] with some modifications, a total of 3 mL peripheral blood was layered onto 6 mL lymphocyte separation medium in a 10 mL test tube and then centrifuged at 1,680×g for 30 min. The cells were washed three times and then suspended in RPMI-1640 complete culture medium supplemented with 10% (v/v) of foetal calf serum, 100 U/mL penicillin, 100 μg/mL streptomycin, and 25 mmol/L of N-(2-hydroxyethyl)-piperazine-N-2-ethane-sulphonic acid. Live cells were detected by trypan blue dye exclusion and counted to adjust density to 2×10^6^ cells/mL.

Cell suspension for180 μL and concanavalin A (Con A, Sigma, Saint Louis MO, USA) for 20 μL were added to each well of a 96-well microtitre plate to provide a final concentration of 5 μg/mL Con A. and then, the plates were incubated at 37°C in a 5% CO~2~ incubator for 66 h, and then 10 μL 5 mg/mL of 3-(4, 5-dimethylthiazol-2-yl)-2, 5 biphenyl tetrazolium (Sigma, Saint Louis, Missouri, USA) was added and the plates were incubated for another 6 h. After incubation, 100 μL of 10% sodium dodecyl sulfate in 0.04 mol/L HCl solution was added to dissolve the MTT crystals. Finally, the plates were read using an automated enzyme-linked immunoassay reader (Tecan, Männedorf, Switzerland) at 570 nm. Lymphocyte proliferation was expressed as a stimulation index, which was calculated as the absorbance of wells incubated with Con A divided by the absorbance of wells incubated without Con A.

Determination of plasma cytokines, hormones and biochemical parameters
----------------------------------------------------------------------

The plasma concentrations of glucose, blood urea nitrogen (BUN), and nonesterified fatty acid (NEFA) were measured with commercial assay kits (Nanjing Jianchen Biological Co. Ltd., Nanjing, China).The plasma concentrations of IL-1β, IL-6, TNF-α, growth hormone (GH), insulin-like growth factor-I (IGF-I), α-acid glycoprotein (α-AGP), and IgG were determined using enzyme-linked immunosorbent assay with kits (R&D Inc., Los Angeles, CA, USA).

RNA extraction and quantitative real-time polymerase chain reaction analysis
----------------------------------------------------------------------------

Total RNA of spleen was extracted using TRIzol reagent (Beijing Dingguo Changsheng Biotech Co. Ltd., Beijing, China) according to the manufacturer's instruction. The purity of RNA preparation was estimated by measuring the optical density (OD) at 260 nm and 280 nm. The OD 260/280 ratio of RNA samples were between 1.8 and 2.0. The RNA integrity was detected using 1% agarose gel electrophoresis and two obvious stripes of 18 s and 28 s were observed, 28 s/18 s ratio in width and brightness was more than 1.5 based on the analysis of biological software.

First-strand cDNA was synthesized in a reverse transcription reaction system of 20 μL containing 0.05 μg/μL of purified total RNA, 0.5 mmol/L oligo dT, 2 mmol/L 5×RT buffer, 0.5 mmol/L dNTP, 1 U/μL RNasin and 10 U/μL reverse transcriptase (MMLV, Toyobo, Osaka, Japan). The synthesized first-strand cDNA samples were diluted by ultra-purified water. Gene expression at mRNA level was analyzed by quantitative real-time polymerase chain reaction (PCR) with specific primers designed by Premier 5.0 software. Gene-specific primers for β-actin (forward: 5′-TGCGGGACATCAAGGAGAAG-3′; reverse: 5′-AGTTGAAGGTAGTTTCGTGG-3′; GenBank sequence No: XM-00312428.1), IL-1β (forward: 5′-TGGCAGTCCTCTGTCCTTG-3′; reverse: 5′-GATCTTTCACAGACACTGCTGC-3′; GenBank sequence No: GI:47522925), IL-6 (forward: 5′-AGTCCAGTCGCCTTCTCCCT-3′; reverse: 5′-CAGAGATTTTGCCGAGGATG-3′; GenBank sequence No: GI:47523851) and TNF-α (forward: 5′-CCACGCTCTTCTGCCTACTG-3′; reverse: 5′-GCTGATGGTGTGAGTGAGGAA-3′; GenBank sequence No: GI:189176152) were synthesized by Dingguo Changsheng Biotech Co. (Beijing, China). PCR was performed in a 20 μL reaction system containing 10 μL 2× Taq RCR Master Mix (Genview, Tempe, AZ, USA), 2 μL cDNA template, 0.5 μmol/L up-premier and down-premier respectively. The real-time PCR cycling conditions were a pre-denaturation cycle at 94°C for 5 min firstly, followed by 35 cycles at 95°C for 30 s, 51°C/55°C/58°C/56°C for 30 s, then 1 cycle at 72°C for 10 min. Amplification and melt-curve analysis were performed in Mx3005P (Agilent Stratagene, Los Angeles, CA, USA). The relative concentration of mRNA was evaluated by the 2^−ΔΔCt^ method ([@b30-ajas-27-7-1035-17]).

Statistical analysis
--------------------

The pen was used as the experimental unit for the analysis of growth performance, whereas individual piglet was used as experimental unit for analysis of blood parameters and spleen pro-inflammatory cytokines. The data for all parameters were recorded for each experimental unit and statistically analyzed by one-way analysis of variance and univariate analysis using (general llinear model) procedures of SPSS 16.0 software (INC SPSS, 2008) basing on the main factors including ASPS treatment and LPS challenge. Difference significance was taken at p\<0.05, and there was tendency toward statistical significance if p\<0.10.

RESULTS
=======

Effect of *Acanthopanax senticosus* polysaccharide on growth performance
------------------------------------------------------------------------

As given in [Table 2](#t2-ajas-27-7-1035-17){ref-type="table"}, prior to LPS challenge (from d 1 to 14), ASPS did not affect performance (p\>0.05). Following LPS challenge (from d 15 to 21), suppressed ADG and ADFI were observed by LPS challenge (p\<0.05). Correspondingly, pigs fed ASPS have a 15.94% higher ADG (p\<0.05) and a 13.77% higher ADFI than those fed non-supplemented control regardless of the challenge, and interaction between LPS×ASPS was also observed on ADG and ADFI (p\<0.05). Through 21-d trial, there was a tendentious interaction on ADG (p\<0.1). In addition, for LPS-challenged pigs fed ASPS had a 35.76% higher ADG and a 33.95% higher ADFI than the non-additive group (p\<0.05), however, ADG and ADFI were insignificant improved by dietary ASPS among saline-injected pigs.

Effect of *Acanthopanax senticosus* polysaccharide on immunological responses
-----------------------------------------------------------------------------

As indicated in [Table 3](#t3-ajas-27-7-1035-17){ref-type="table"}, LPS challenge improved lymphocyte proliferation (p\<0.05), lymphocyte to leucocyte ratio (p\<0.1), and leucocyte number (p\<0.05). Dietary ASPS significantly promoted lymphocyte proliferation (p\<0.05) and leucocyte number (p\<0.1) compared with the non-additive group and ignoring LPS challenge. There was no LPS×ASPS interaction revealed on these indices except lymphocyte proliferation (p\<0.05). However, circulatory concentration of IgG was influenced (p\>0.05) neither by ASPS, LPS nor their interaction. ASPS supplementation improved lymphocyte proliferation among saline-injected and LPS-injected pigs.

The plasma cytokines concentration and spleen expression of proinflammatory cytokines mRNA
------------------------------------------------------------------------------------------

As presented in [Table 4](#t4-ajas-27-7-1035-17){ref-type="table"}, the plasma concentration of IL-1β, IL-6, and TNF-α were induced to increase (p\<0.05) by LPS challenge. In contrast, these indices were decreased by dietary ASPS (p\<0.05), and an interaction between ASPS× LPS was found on these cytokines. Dietary ASPS also resulted in down-regulation (p\<0.05) of IL-1β, IL-6, and TNF-α mRNA expression in spleen, and ASPS×LPS interaction were detected on mRNA expression of IL-1β as well as IL-6 (p\<0.05). In addition, for LPS-challenged pigs, dietary ASPS significantly reduced the circulating concentration and mRNA expression of IL-1β, IL-6 as well as TNF-α (p\<0.05) compared with non-supplemented group. Whereas, ASPS had no effect on these indices among saline-injected pigs.

Plasma hormones and biochemical parameters analysis
---------------------------------------------------

As showed in [Table 5](#t5-ajas-27-7-1035-17){ref-type="table"}, decreased plasma concentration of GH and IGF-I were revealed (p\<0.05) in pigs suffering from LPS challenge. Correspondingly, GH and IGF-I concentrations were increased (p\<0.05) in pigs fed ASPS regardless of LPS challenge. ASPS additive also significantly lowered (p\<0.05) the concentration of α-AGP, BUN, NEFA, and glucose. Moreover, interaction effects were observed on above indices (p\<0.05) except GH (p\>0.05) and BUN (p\<0.1). For the LPS-injected pigs, dietary ASPS lowered plasma GH, IGF-I, α-AGP, NEFA, and glucose (p\<0.05) than non-additive group.

DISCUSSION
==========

In the current study, the well-documented piglets infected model built by injecting LPS ([@b14-ajas-27-7-1035-17]; [@b25-ajas-27-7-1035-17]), which is a molecule present on the membrane of gram-negative bacteria, was used to evaluate the effect of dietary ASPS on immunological challenge. Our finding that LPS challenge reduced their performance is consistent with previous research in pigs ([@b9-ajas-27-7-1035-17]) and indicates the suitability of the challenge model in our study.

In recent years, there has been increasing interest in using polysaccharides to improve growth performance in young animals ([@b24-ajas-27-7-1035-17]; [@b28-ajas-27-7-1035-17]). However, to our knowledge, little research was conducted to determine the effect that ASPS exerted on growth performance in weanling pigs. In the present study, the results of dietary ASPS improving the growing rate of piglets were similar to [@b47-ajas-27-7-1035-17] who found that growth performance of weaned pigs were increased by the addition of AS extracts (ASE), which contains compound active ingredients besides polysaccharide. Furthermore, ASPS supplementation insignificantly affected performance before LPS challenge. Coactions between ASPS and LPS were observed on ADG and ADFI following LPS challenge suggesting that dietary ASPS can alleviate the detrimental performance induced by LPS immunological stress. At the same time, it also clearly indicated a more important effect of dietary ASPS under stress than under normal conditions.

In the current study, the blood cell number, lymphocyte proliferation and antibody were measured to determine the role of ASPS on ability to resist pathogens and the immune response during immunological challenge. Leukocytes and lymphocyte serving as important components of the innate immune system can recognize non-specifically different pathogens and can predict underlying infection ([@b33-ajas-27-7-1035-17]) or stress ([@b31-ajas-27-7-1035-17]). Therefore, in the present study, an increase in circulating leukocytes number and lymphocyte to leukocyte ratio after challenge accords with the research by [@b31-ajas-27-7-1035-17] to imply an underlying bacterial infection or stress in piglets. However, ASPS supplementation tendentious increased of leukocyte number suggesting a latent role of ASPS in enhancing resistance to disease.

Lymphocyte proliferation stimulated by Con A can be indicative of cellular immunity. Our study concerning the markedly improved lymphocyte proliferation activity indicates an activated immune system by LPS challenge. At same time, ASPS supplementation improved lymphocyte proliferation among LPS-injected and saline-injected pigs, which was in agreement with previous study by [@b3-ajas-27-7-1035-17] suggesting that lymphocyte proliferative responses of mice spleen induced by Con A was enhanced by ASPS *in vitro*. [@b20-ajas-27-7-1035-17] demonstrated that ASE can enhance cellular responses of weaned piglets, highlight the enhanced immunostimulating effect of ASPS on cellular immunity, which was also similar to the research by [@b24-ajas-27-7-1035-17] who reported that Chinese yam polysaccharide enhanced cellular immune response in weanling rats. The plasma IgG serves as an important criterion of humoral immunity which has the effect of strengthening phagocytosis of bacteria by the immune cell. Our finding of an insignificant effect on IgG by dietary ASPS might suggest its inefficacy in improving humoral immunity. As a matter of fact, a dissimilar result by [@b20-ajas-27-7-1035-17] suggested that serum IgG concentration in pigs was enhanced by ASE. [@b12-ajas-27-7-1035-17] also demonstrated ASPS selectively activated B cells rather than T cells in mice. The contradictory results between our study and previous reports may be associated with the species of experimental animal and the method of extracting herbal ingredients. Collectively, these results suggest that dietary ASPS maybe improve cellular immunity, and the underlying mechanism for improving lymphocyte proliferation by ASPS needs further research.

The release of pro-inflammatory cytokines to activate immune system during the period of immunological stress is critical for improving immune response and resistance ([@b15-ajas-27-7-1035-17]). However, excessive secretion of these cytokines can reduce feed intake, direct nutrients in support of immune function and ultimately reduces growth ([@b40-ajas-27-7-1035-17]). In our study, the sharply elevated circulating concentration of IL-1β, IL-6, and TNF-α, especially spleen mRNA expression of these cytokines following LPS challenge indicate the immune response was speedy and excessive activated, which is agreement with [@b9-ajas-27-7-1035-17] and [@b25-ajas-27-7-1035-17]. For the pigs given LPS, the findings concerning diet with ASPS lowering circulating concentrations and mRNA expression of spleen pro-inflammatory cytokines suggest that ASPS supplementation contributes to a less activated immune system and more nutrients directed to support growth. These results propose that decrease in excessive activation of the immune system may be the mechanism by which growth and feed intake are improved when ASPS is included in post-weaning diet. This may partially explain the reason of higher performance obtained in LPS-administrated pigs fed ASPS.

As the important component of somatotropic axis, GH is a key anabolic hormone and its anabolic action is accomplished in part by the induction of IGF-I ([@b13-ajas-27-7-1035-17]). In the present study, reducted concentration of circulatory GH and IGF-I was revealed in pigs given LPS administration, and is in accordance with the previous reports by [@b6-ajas-27-7-1035-17] and [@b9-ajas-27-7-1035-17]. Previous research also suggested that the decrease in IGF-I was the important indicator of repartitioning of nutrients away from growth to immune function during immunological challenge ([@b39-ajas-27-7-1035-17]; [@b46-ajas-27-7-1035-17]). Therefore, the observed interaction between LPS and ASPS on IGF-I indicates the mitigated decrease in IGF-I owning to ASPS supplementation may be associated with alleviating the abnormal changes of somatotropic axis and improving growth performance among LPS challenged pigs fed ASPS.

Previous research by [@b18-ajas-27-7-1035-17] and [@b15-ajas-27-7-1035-17] proposed that pro-inflammatory cytokines released during immunological challenge are major mediators of intermediary metabolism. These cytokines reduced glucose uptake by the organisms tissues ([@b26-ajas-27-7-1035-17]; [@b29-ajas-27-7-1035-17]), increased plasma NEFA derived from adipose tissue ([@b32-ajas-27-7-1035-17]), elevated circulatory BUN ([@b45-ajas-27-7-1035-17]; [@b27-ajas-27-7-1035-17]) and accelerated muscle protein degradation in synthesis of α-AGP in liver ([@b37-ajas-27-7-1035-17]), which are an important hallmarks of an immunological response ([@b15-ajas-27-7-1035-17]). Above previous reports rationally interprets why increased circulatory α-AGP, BUN, NEFA as well as glucose occurred in the current study after LPS administration. Correspondingly, the results of LPS-administrated pigs fed with ASPS showing a significant attenuated the reduction of α-AGP, NEFA, and glucose compared with those fed with non-additive confirmed the enhanced anabolism of challenged animals and suggests that dietary ASPS involved in regulating growth inhibition might be closely related to the suppression of the release of pro-inflammatory cytokines.

CONCLUSION
==========

The present study demonstrates that ASPS additive to the diet of piglets could mitigate the excessive immunological response to LPS challenge by modulating the release of pro-inflammatory cytokines, which enable pigs to achieve better growth performance. These results suggest that lowering excessive activation of immune system may be the mechanism by which growth rate and feed intake are improved when ASPS is used as natural derived immunomodulating agent of weaned pigs.

The work was supported by National "Twelfth Five-Year" Plan for Science and Technology Support Program (2011BAD28B01-02).

###### 

Ingredient composition and nutrient contents of the basal diet (%, as-fed basis)

  Items                                                                           
  ------------------------------------------------------------------------------- ------
  Ingredient composition (%)                                                      
   Corn                                                                           52.4
   Soybean meal                                                                   24.0
   Whey power                                                                     8.0
   Fish meal                                                                      4.0
   Soybean oil                                                                    2.3
   Sucrose                                                                        5.0
   Limestone                                                                      0.8
   Dibasic calcium phosphate                                                      1.2
   Salt                                                                           0.3
   L-lysine                                                                       0.35
   DL-methionine                                                                  0.05
   L-threonine                                                                    0.18
   Tryptophan                                                                     0.02
   Choline chloride                                                               0.1
   Complex acidifying agent                                                       0.3
   Vitamin and mineral pre-mix[1](#tfn1-ajas-27-7-1035-17){ref-type="table-fn"}   1
  Nutrient content[2](#tfn2-ajas-27-7-1035-17){ref-type="table-fn"}               
   Metabolizable energy (Mcal/kg)                                                 3.44
   Crude protein (%)                                                              19.1
   Calcium (%)                                                                    0.86
   Available phosphorus (%)                                                       0.65
   Lysine (%)                                                                     1.36
   Methionine (%)                                                                 0.38

Vitamin premix containing (per kg): vitamin A 12,000 IU; vitamin D~3~ 3,000 IU; vitamin E 60 IU; vitamin K~3~ 3 mg; thiamine 3 mg; riboflavin 7.5 mg; niacin 45 mg; pantothenic acid 30 mg; pyridoxine 4.8 mg; vitamin B~12~ 0.04 mg; folic acid 1.2 mg; biotin 0.22 mg; Cu (copper sulfate) 15 mg; Zn (zinc sulfate) 120 mg; Fe (ferrous sulfate) 120 mg; Mn (manganese sulfate) 50 mg; I (calcium iodate) 0.6 mg; Se (sodium selenite) 0.3 mg.

Crude protein, calcium, phosphorus were analyzed values. The metabolizable energy and amino acid contents were calculated.

###### 

Effect of dietary ASPS supplementation on performance of weaned piglets challenged with LPS[1](#tfn4-ajas-27-7-1035-17){ref-type="table-fn"}

  Items         −LPS                                                     +LPS                                                     SEM                                                      p-value                                                                          
  ------------- -------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- ------- ------- ------- -------
  ADG (kg)                                                                                                                                                                                                                                                                  
   d 1 to14     0.227                                                    0.235                                                    0.229                                                    0.232                                                    0.011   0.634   0.953   0.853
   d 15 to 21   0.473[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.483[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.330[b](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.448[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.024   0.019   0.003   0.042
   d 1 to 21    0.309[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.318[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.262[b](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.304[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.008   0.007   0.002   0.054
  ADFI (kg)                                                                                                                                                                                                                                                                 
   d 1 to14     0.349                                                    0.365                                                    0.348                                                    0.353                                                    0.023   0.655   0.782   0.811
   d 15 to 21   0.880[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.871[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.645[b](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.864[a](#tfn5-ajas-27-7-1035-17){ref-type="table-fn"}   0.033   0.013   0.002   0.008
   d 1 to 21    0.526                                                    0.534                                                    0.447                                                    0.517                                                    0.022   0.107   0.054   0.188
  Gain:feed                                                                                                                                                                                                                                                                 
   d 1 to14     0.652                                                    0.647                                                    0.657                                                    0.687                                                    0.025   0.814   0.692   0.758
   d 15 to 21   0.538                                                    0.556                                                    0.520                                                    0.521                                                    0.029   0.824   0.534   0.850
   d 1 to 21    0.588                                                    0.596                                                    0.588                                                    0.602                                                    0.071   0.767   0.949   0.934

ASPS, *Acanthopanax senticosus* polysaccharide; LPS, lipopolysaccharide; SEM, standard error of the mean; ADG, average daily gain; ADFI, average daily feed intake.

Values were represented as means of four pens with four pigs per pen.

Different superscript in a row indicates significant difference at p\<0.05.

###### 

Effect of dietary ASPS supplementation on peripheral immune parameters of weaned piglets challenged with LPS[1](#tfn7-ajas-27-7-1035-17){ref-type="table-fn"}

  Items                                                                       −LPS                                                     +LPS                                                     SEM                                                       p-value                                                                         
  --------------------------------------------------------------------------- -------------------------------------------------------- -------------------------------------------------------- --------------------------------------------------------- -------------------------------------------------------- ------ ------ -------- ------
  IgG (g/L)                                                                   8.74                                                     7.92                                                     8.28                                                      8.66                                                     0.26   0.80   0.69     0.29
  Lymphocyte proliferation[2](#tfn8-ajas-27-7-1035-17){ref-type="table-fn"}   1.63[a](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}    1.72[b](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}    1.75[b](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}     1.78[c](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}    0.02   0.02   \<0.01   0.04
  Lymphocyte to leucocyte ratio (%)                                           48.58                                                    50.22                                                    54.05                                                     70.14                                                    3.87   0.24   0.10     0.33
  Leucocyte number (10^9^/L)                                                  21.88[a](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}   17.58[a](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}   24.93[ab](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}   31.68[b](#tfn9-ajas-27-7-1035-17){ref-type="table-fn"}   2.58   0.05   \<0.01   0.63

ASPS, *Acanthopanax senticosus* polysaccharide; LPS, lipopolysaccharide; SEM, standard error of the mean.

Values represent the means of four pens with one pig per pen.

Values are expressed as stimulation index calculated as the ratios of absorbance of wells incubated with Con A to absorbance of wells incubated without Con A.

Different superscript in a row indicates significant difference at p\<0.05.

###### 

Effects of dietary ASPS supplementation on plasma concentration of pro-inflammatory cytokines and its relative mRNA level in spleen of weaned piglets challenged with LPS[1](#tfn11-ajas-27-7-1035-17){ref-type="table-fn"}

  Items          −LPS                                                       +LPS                                                       SEM                                                        p-value                                                                              
  -------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ------- -------- -------- --------
  IL-1β (ng/L)   264.06[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   265.72[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   337.86[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   270.44[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   12.50   0.02     \<0.01   0.02
  IL-6 (ng/L)    39.71[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}    40.21[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}    56.50[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}    40.02[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}    2.93    0.02     0.02     0.01
  TNF-α (ng/L)   284.92[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   292.62[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   366.20[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   279.73[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}   15.05   0.02     0.04     \<0.01
  IL-1 β mRNA    0.12[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.01[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     26.61[c](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}    8.38[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     3.37    \<0.01   \<0.01   0.04
  IL-6 mRNA      0.11[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.09[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     5.58[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.15[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.71    \<0.01   \<0.01   \<0.01
  TNF-α mRNA     0.80[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.66[a](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     3.81[c](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     2.83[b](#tfn12-ajas-27-7-1035-17){ref-type="table-fn"}     0.42    0.04     \<0.01   0.10

ASPS, *Acanthopanax senticosus* polysaccharide; LPS, lipopolysaccharide; SEM, standard error of the mean; IL-1β, interleukin-1beta; IL-6, interleukin-6; TNF-α, tumor necrosis factor-alpha.

Values represent the means of four pens with one pig per pen.

Different superscript in a row indicates significant difference at p\<0.05.

###### 

Effect of dietary ASPS supplementation on some plasma parameters of weaned piglets challenged with LPS[1](#tfn14-ajas-27-7-1035-17){ref-type="table-fn"}

  Items              −LPS                                                       +LPS                                                       SEM                                                        p-value                                                                              
  ------------------ ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ---------------------------------------------------------- ------- -------- -------- -------
  GH (μg/L)          17.12[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    17.501[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   15.47[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    17.17[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    0.46    0.04     0.049    0.17
  IGF- I (μg/L)      122.18[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   124.02[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   110.31[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   123.53[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   2.60    0.01     0.035    0.049
  α-AGP^3^ (ng/L)    147.38[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   131.68[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   186.61[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   136.75[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   6.58    \<0.01   \<0.01   0.03
  BUN (mmol/L)       14.07[ab](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   8.60[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}     18.83[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    14.59[ab](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   1.32    0.03     0.049    0.09
  NEFA (μmol/L)      62.64[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    51.17[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}    322.60[c](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   265.22[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}   42.68   0.02     0.02     0.02
  Glucose (mmol/L)   2.23[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}     1.57[b](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}     2.29[a](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}     1.82[c](#tfn15-ajas-27-7-1035-17){ref-type="table-fn"}     0.27    0.04     0.01     0.03

ASPS, *Acanthopanax senticosus* polysaccharide; LPS, lipopolysaccharide; SEM, standard error of the mean; GH, growth hormone; IGF-I, insulin-like growth factor-I; α-AGP, α-acid glycoprotein; BUN, blood urea nitrogen; NEFA, nonesterified fatty acid.

Values represent the means of four pens with one pig per pen.

Different superscript in a row indicates significant difference at p\<0.05.

[^1]: College of Animal Science and Veterinary Science, Shenyang Agricultural University, Shenyang 110-866, China
